Diferencia entre revisiones de «Harbor:Creatinine screening prior to IV contrast»
Sin resumen de edición |
|||
| Línea 13: | Línea 13: | ||
## recent use of nephrotoxic medication (eg, aminoglycosides) | ## recent use of nephrotoxic medication (eg, aminoglycosides) | ||
#If the study is immediately necessary to prevent life-threatening decompensation or delay in emergent treatment | #If the study is immediately necessary to prevent life-threatening decompensation or delay in emergent treatment | ||
==See Also== | |||
==Source== | ==Source== | ||
*American College of Radiology Manual on Contrast Administration | *American College of Radiology Manual on Contrast Administration | ||
*Harbor-UCLA Medical Center Policy, "Emergency Department Creatinine Screening Guidelines for Radiographic Evaluations" | *Harbor-UCLA Medical Center Policy, "Emergency Department Creatinine Screening Guidelines for Radiographic Evaluations" | ||
[[Category:Rads]] | |||
[[Category:Renal]] | |||
Revisión del 00:10 1 sep 2011
Background
To expedite the appropriate use of creatinine screening in ED patients requiring IV contrast for CT or other radiographic evaluation
Guideline
ED patients do NOT require Cr measurement prior to IV contrast if:
- They are <60 years old AND do NOT have
- history of kidney failure or transplant
- family history of kidney failure
- diabetes, hypertension
- collagen vascular disease (eg, SLE, scleroderma, rheumatoid arthritis)
- paraproteinemia syndrome (eg, myeloma)
- recent use of nephrotoxic medication (eg, aminoglycosides)
- If the study is immediately necessary to prevent life-threatening decompensation or delay in emergent treatment
See Also
Source
- American College of Radiology Manual on Contrast Administration
- Harbor-UCLA Medical Center Policy, "Emergency Department Creatinine Screening Guidelines for Radiographic Evaluations"